Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard H Chapple

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|July 18, 2018
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancerCaitlin L Grzeskowiak, Samrat T Kundu, Xiulei Mo, et al.
Genome Biology|June 19, 2024
An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programsRichard H Chapple, Xueying Liu, Sivaraman Natarajan, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programsRichard H Chapple, Xueying Liu, Sivaraman Natarajan, et al.
Nature Communications|February 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acidMin Pan, Yinwen Zhang, William C Wright, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acidMin Pan, Yinwen Zhang, William C Wright, et al.
Nature Communications|November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, William C Wright, Richard H Chapple, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneityAnand G Patel, Orr Ashenberg, Natalie B Collins, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|July 18, 2018
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancerCaitlin L Grzeskowiak, Samrat T Kundu, Xiulei Mo, et al.
Genome Biology|June 19, 2024
An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programsRichard H Chapple, Xueying Liu, Sivaraman Natarajan, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programsRichard H Chapple, Xueying Liu, Sivaraman Natarajan, et al.
Nature Communications|February 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acidMin Pan, Yinwen Zhang, William C Wright, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acidMin Pan, Yinwen Zhang, William C Wright, et al.
Nature Communications|November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, William C Wright, Richard H Chapple, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneityAnand G Patel, Orr Ashenberg, Natalie B Collins, et al.
Pageof 2